Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 108

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Bacterial Persister Cells and Development of Antibiotic Resistance in Chronic Infections: An Update

Kunnath, Anil Philip, Suodha Suoodh, Mohamed, Chellappan, Dinesh Kumar, Chellian, Jestin, Palaniveloo, Kishneth · 2024 · British Journal of Biomedical Science

Abstract

The global issue of antimicrobial resistance poses significant challenges to public health. The World Health Organization (WHO) has highlighted it as a major global health threat, causing an estimated 700,000 deaths worldwide. Understanding the multifaceted nature of antibiotic resistance is crucial for developing effective strategies. Several physiological and biochemical mechanisms are involved in the development of antibiotic resistance. Bacterial cells may escape the bactericidal actions of the drugs by entering a physiologically dormant state known as bacterial persistence. Recent findings in this field suggest that bacterial persistence can be one of the main sources of chronic infections. The antibiotic tolerance developed by the persister cells could tolerate high levels of antibiotics and may give rise to persister offspring. These persister offspring could be attributed to antibiotic resistance mechanisms, especially in chronic infections. This review attempts to shed light on persister-induced antibiotic resistance and the current therapeutic strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/bjbs.2024.12958

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 130

  1. Ronneau, 2021, Antibiotic Persistence and Tolerance: Not Just One and the Same, Curr Opin Microbiol, 64, 76, 10.1016/j.mib.2021.09.017 · DOI
  2. Dawan, 2020, Role of Antibiotic Stress in Phenotypic Switching to Persister Cells of Antibiotic-Resistant Staphylococcus aureus, Ann Microbiol, 70, 1, 10.1186/s13213-020-01552-1 · DOI · Paper page
  3. Kalani, 2024, Are Bacterial Persister Cells Really the Cause of Infection Relapse/Recalcitrance?, J Basic Res Med Sci, 11
  4. Ahmady, 2024, Antifungal Drug Resistance in Candida: A Special Emphasis on Amphotericin B, APMIS, 132, 291, 10.1111/apm.13389 · DOI
  5. Baquero, 2024, Bacteriostatic Cells Instead of Bacteriostatic Antibiotics?, Mbio, 15, e0268023, 10.1128/mbio.02680-23 · doi:10.1128/mbio.02680-23
  6. Song, 2021, Are We Really Studying Persister Cells?, Environ Microbiol Rep, 13, 3, 10.1111/1758-2229.12849 · DOI
  7. Kaplan, 2021, Observation of Universal Ageing Dynamics in Antibiotic Persistence, Nature, 600, 290, 10.1038/s41586-021-04114-w · DOI
  8. Gollan, 2019, Bacterial Persisters and Infection: Past, Present, and Progressing, Annu Rev Microbiol, 73, 359, 10.1146/annurev-micro-020518-115650 · DOI · Paper page
  9. Huemer, 2021, Molecular Reprogramming and Phenotype Switching in Staphylococcus Aureus Lead to High Antibiotic Persistence and Affect Therapy Success, Proc Natl Acad Sci, 118, e2014920118, 10.1073/pnas.2014920118 · DOI
  10. Planet, 2022, Adaptation and Evolution of Pathogens in the Cystic Fibrosis Lung, J Pediatr Infect Dis Soc, 11, S23, 10.1093/jpids/piac073 · DOI
  11. Sommerfield, 2024, In Vivo and in Vitro Analysis of the Role of the Prc Protease in Inducing Mucoidy in
  12. Chung, 2023, How Three Self-Secreted Biofilm Exopolysaccharides of pseudomonas Aeruginosa, Psl, Pel, and Alginate, Can Each Be Exploited for Antibiotic Adjuvant Effects in Cystic Fibrosis Lung Infection, Int J Mol Sci, 24, 8709, 10.3390/ijms24108709 · DOI
  13. Liong, 2024, Pseudomonas Aeruginosa: The Whats, Whys, and Hows of Bacterial Efflux, J High Sch Sci, 8, 122
  14. Kameswaran, 2024, Quenching and Quorum Sensing in Bacterial Bio-Films, Res Microbiol, 175, 104085, 10.1016/j.resmic.2023.104085 · DOI
  15. García-Villada, 2024, A Role for the Stringent Response in Ciprofloxacin Resistance in Pseudomonas Aeruginosa, Scientific Rep, 14, 8598, 10.1038/s41598-024-59188-z · DOI
  16. Gebreyohannes, 2019, Challenges of Intervention, Treatment, and Antibiotic Resistance of Biofilm-Forming Microorganisms, Heliyon, 5, e02192, 10.1016/j.heliyon.2019.e02192 · DOI · Paper page
  17. Conlon, 2015, Persister Cells in Biofilm Associated Infections, 1, 10.1007/978-3-319-09782-4_1 · DOI · Paper page
  18. Surekha, 2024, Antibiotic Resistant Biofilms and the Quest for Novel Therapeutic Strategies, Indian J Microbiol, 64, 20, 10.1007/s12088-023-01138-w · DOI
  19. He, 2023, Antibiotic Treatment Can Exacerbate Biofilm-Associated Infection by Promoting Quorum Cheater Development, npj Biofilms and Microbiomes, 9, 26, 10.1038/s41522-023-00394-4 · DOI
  20. Too, 2024, The Interconnection Between Virulence Factors, Biofilm Formation, and Horizontal Gene Transfer in Enterococcus: A Review, 10.5772/intechopen.114321 · DOI
  21. Li, 2023, Insights Into the Role of Extracellular Polymeric Substances (EPS) in the Spread of Antibiotic Resistance Genes, Environ Pollut, 343, 123285, 10.1016/j.envpol.2023.123285 · DOI
  22. Zhou, 2023, Deciphering the Distribution and Microbial Secretors of Extracellular Polymeric Substances Associated Antibiotic Resistance Genes in Tube Wall Biofilm, Sci Total Environ, 881, 163218, 10.1016/j.scitotenv.2023.163218 · DOI
  23. Singh, 2022, Bacterial Biofilm Infections, Their Resistance to Antibiotics Therapy and Current Treatment Strategies, Biomed Mater, 17, 022003, 10.1088/1748-605X/ac50f6 · DOI
  24. Lewis, 2008, Quasi-Periodic Bedding in the Sedimentary Rock Record of Mars, 1532
  25. Levin-Reisman, 2017, Antibiotic Tolerance Facilitates the Evolution of Resistance, Science, 355, 826, 10.1126/science.aaj2191 · DOI · Paper page
  26. Gutierrez, 2013, β-Lactam Antibiotics Promote Bacterial Mutagenesis Via an RpoS-Mediated Reduction in Replication Fidelity, Nat Commun, 4, 1610, 10.1038/ncomms2607 · DOI · Paper page
  27. Kochanowski, 2024, Bacteria Colonies Modify Their Shear and Compressive Mechanical Properties in Response to Different Growth Substrates, ACS Appl Bio Mater, 10.1021/acsabm.3c00907 · DOI
  28. Grande, 2020, Antibiotic Resistance and Bacterial Biofilm, Expert Opin Ther Patents, 30, 897, 10.1080/13543776.2020.1830060 · DOI
  29. Ali, 2023, Microbial Biofilms: Applications, Clinical Consequences, and Alternative Therapies, Microorganisms, 11, 1934, 10.3390/microorganisms11081934 · DOI
  30. Perikleous, 2023, Antibiotic Resistance in Patients With Cystic Fibrosis: Past, Present, and Future, Antibiotics, 12, 217, 10.3390/antibiotics12020217 · DOI
  31. Herrera-Hidalgo, 2023, Treatment of Enterococcus Faecalis Infective Endocarditis: A Continuing Challenge, Antibiotics, 12, 704, 10.3390/antibiotics12040704 · DOI
  32. Mendhe, 2023, Impact of Biofilms on Chronic Infections and Medical Challenges, Cureus, 15, e48204, 10.7759/cureus.48204 · DOI
  33. Ammons, 2010, Antibiofilm Strategies and the Need for Innovations in Wound Care, Recent Pat Antiinfect Drug Discov, 5, 10, 10.2174/157489110790112581 · DOI
  34. Usui, 2023, Intermittent Antibiotic Treatment of Bacterial Biofilms Favors the Rapid Evolution of Resistance, Commun Biol, 6, 275, 10.1038/s42003-023-04601-y · DOI
  35. Chen, 2022, The Stress Response Mechanisms of Biofilm Formation Under Sub-Lethal Photocatalysis, Appl Catal B: Environ Energ, 307, 121200, 10.1016/j.apcatb.2022.121200 · DOI
  36. Moser, 2021, Immune Responses to Pseudomonas Aeruginosa Biofilm Infections, Front Immunol, 12, 625597, 10.3389/fimmu.2021.625597 · DOI · Paper page
  37. Pan, 2023, Recent Advances in Bacterial Persistence Mechanisms, Int J Mol Sci, 24, 14311, 10.3390/ijms241814311 · DOI
  38. Zou, 2022, Are Bacterial Persisters Dormant Cells Only?, Front Microbiol, 12, 708580, 10.3389/fmicb.2021.708580 · DOI
  39. Naudin, 2024, Development of an In Vitro Biofilm Model for the Study of the Impact of Fluoroquinolones on Sewer Biofilm Microbiota, Front Microbiol, 15, 1377047, 10.3389/fmicb.2024.1377047 · doi:10.3389/fmicb.2024.1377047
  40. Kaushik, 2022, Interaction of RecA Mediated SOS Response With Bacterial Persistence, Biofilm Formation, and Host Response, Int J Biol Macromolecules, 217, 931, 10.1016/j.ijbiomac.2022.07.176 · DOI
  41. Mulcahy, 2010, Emergence of Pseudomonas Aeruginosa Strains Producing High Levels of Persister Cells in Patients With Cystic Fibrosis, J Bacteriol, 192, 6191, 10.1128/JB.01651-09 · DOI · Paper page
  42. Kaur, 2023, Antifungal Drug-Resistance Mechanisms in Candida Biofilms, Curr Opin Microbiol, 71, 102237, 10.1016/j.mib.2022.102237 · DOI · Paper page
  43. Uruén, 2021, Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance, Antibiotics, 10, 3, 10.3390/antibiotics10010003 · DOI · Paper page
  44. Trubenová, 2022, Population Genetics, Biofilm Recalcitrance, and Antibiotic Resistance Evolution, Trends Microbiol, 30, 841, 10.1016/j.tim.2022.02.005 · DOI
  45. Sun, 2019, Editorial: Horizontal Gene Transfer Mediated Bacterial Antibiotic Resistance, Front Microbiol, 10, 1933, 10.3389/fmicb.2019.01933 · DOI · Paper page
  46. Poonam, 2022, Role of Horizontal Gene Transfer in the Dissemination of Antimicrobial Resistance in Food Animal Production, Curr Opin Food Sci, 47, 100882, 10.1016/j.cofs.2022.100882 · DOI
  47. GlauberAraújo, 2019, The Mechanical Properties of Microbial Surfaces and Biofilms, Cell Surf, 5, 100028, 10.1016/j.tcsw.2019.100028 · DOI
  48. Trubenová, 2022, Population Genetics, Biofilm Recalcitrance, and Antibiotic Resistance Evolution, Trends Microbiology, 30, 841, 10.1016/j.tim.2022.02.005 · DOI
  49. Lebeaux, 2014, Biofilm-Related Infections: Bridging the Gap Between Clinical Management and Fundamental Aspects of Recalcitrance Toward Antibiotics, Microbiol Mol Biol Rev, 78, 510, 10.1128/MMBR.00013-14 · DOI · Paper page
  50. Gabrilska, 2015, Biofilm Models of Polymicrobial Infection, Future Microbiol, 10, 1997, 10.2217/fmb.15.109 · DOI
  51. Zhu, 2015, Physicochemical Characteristics and Microbial Community Evolution of Biofilms During the Start-Up Period in a Moving Bed Biofilm Reactor, J Bioresour Tech, 180, 345, 10.1016/j.biortech.2015.01.006 · DOI · Paper page
  52. Stewart, 2001, Antibiotic Resistance of Bacteria in Biofilms, Lancet, 358, 135, 10.1016/s0140-6736(01)05321-1 · DOI · Paper page
  53. Jensen, 2017, Antibiotics Disrupt Coordination Between Transcriptional and Phenotypic Stress Responses in Pathogenic Bacteria, Cell Rep, 20, 1705, 10.1016/j.celrep.2017.07.062 · DOI
  54. Singh, 2021, Bacterial Exo-Polysaccharides in Biofilms: Role in Antimicrobial Resistance and Treatments, J Genet Eng Biotechnol, 19, 140, 10.1186/s43141-021-00242-y · DOI · Paper page
  55. Sharma, 2019, Antibiotics Versus Biofilm: An Emerging Battleground in Microbial Communities, Antimicrob Resist Infect Control, 8, 76, 10.1186/s13756-019-0533-3 · DOI · Paper page
  56. Tiwari, 2024, Recent Strategies Inhibiting Quorum Sensing and Biofilm Formation in Bacteria to Combat Antibacterial Drug Resistance, 209, 10.4018/979-8-3693-1540-8.ch009 · DOI
  57. Ding, 2022, Subinhibitory Antibiotic Concentrations Promote the Horizontal Transfer of Plasmid-Borne Resistance Genes From Klebsiellae Pneumoniae to Escherichia Coli, Front Microbiol, 13, 1017092, 10.3389/fmicb.2022.1017092 · DOI
  58. Obando, 2024, Dissecting Cell Heterogeneities in Bacterial Biofilms and Their Implications for Antibiotic Tolerance, Curr Opin Microbiol, 78, 102450, 10.1016/j.mib.2024.102450 · DOI
  59. Pizzolato-Cezar, 2023, Bacterial Toxin-Antitoxin Systems: Novel Insights on Toxin Activation Across Populations and Experimental Shortcomings, Curr Res Microb Sci, 5, 100204, 10.1016/j.crmicr.2023.100204 · DOI
  60. Grabe, 2024, Molecular Stripping Underpins Derepression of a Toxin–Antitoxin System, Nat Struct Mol Biol, 31, 1050, 10.1038/s41594-024-01253-2 · doi:10.1038/s41594-024-01253-2
  61. Harms, 2016, Mechanisms of Bacterial Persistence During Stress and Antibiotic Exposure, Science, 354, aaf4268, 10.1126/science.aaf4268 · DOI · Paper page
  62. Yang, 2017, Toxin-Antitoxin Systems and Their Role in Disseminating and Maintaining Antimicrobial Resistance, FEMS Microbiol Rev, 41, 343, 10.1093/femsre/fux006 · DOI · Paper page
  63. Shore, 2024, Type I Toxin-Antitoxin Systems in Bacteria: From Regulation to Biological Functions, EcoSal Plus, eesp00252022, 10.1128/ecosalplus.esp-0025-2022 · DOI
  64. Sonika, 2023, Toxin-Antitoxin Systems in Bacterial Pathogenesis, Heliyon, 9, e14220, 10.1016/j.heliyon.2023.e14220 · DOI
  65. Qiu, 2022, Toxin-Antitoxin Systems: Classification, Biological Roles, and Applications, Microbiol Res, 264, 127159, 10.1016/j.micres.2022.127159 · DOI
  66. Harms, 2018, Toxins, Targets and Triggers: An Overview of Toxin-Antitoxin Biology, Mol Cell, 70, 768, 10.1016/j.molcel.2018.01.003 · DOI · Paper page
  67. Singh, 2021, Bacterial Toxin-Antitoxin Modules: Classification, Functions, and Association With Persistence, Curr Res Microb Sci, 2, 100047, 10.1016/j.crmicr.2021.100047 · DOI
  68. Hong, 2012, Bacterial Persistence Increases as Environmental Fitness Decreases, Microb Biotechnol, 5, 509, 10.1111/j.1751-7915.2011.00327.x · DOI · Paper page
  69. Al Marjani, 2020, Toxin–Antitoxin Systems and Biofilm Formation in Bacteria, Rev Res Med Microbiol, 31, 61, 10.1097/mrm.0000000000000184 · DOI
  70. Leszczynska, 2013, Theformation of Persister Cells in Stationary-Phase Cultures of Escherichia Coliis Associated With the Aggregation of Endogenous Proteins, PLOS ONE, 8, e54737, 10.1371/journal.pone.0054737 · DOI
  71. Maisonneuve, 2013, (p)ppGpp Controls Bacterial Persistence by Stochastic Induction of Toxin-Antitoxin Activity, Cell, 154, 1140, 10.1016/j.cell.2013.07.048 · DOI · Paper page
  72. Jurėnas, 2022, Biology and Evolution of Bacterial Toxin–Antitoxin Systems, Nat Rev Microbiol, 20, 335, 10.1038/s41579-021-00661-1 · DOI · Paper page
  73. Cabral, 2018, Antibiotic Persistence as a Metabolic Adaptation: Stress, Metabolism, the Host, and New Directions, Pharmaceuticals (Basel)., 11, 14, 10.3390/ph11010014 · DOI
  74. Maisonneuve, 2011, Bacterial Persistence by RNA Endonucleases, Proc Natl Acad Sci USA, 108, 13206, 10.1073/pnas.1100186108 · DOI · Paper page
  75. Fraikin, 2019, Reassessing the Role of the Type II MqsRA Toxin-Antitoxin System in Stress Response and Biofilm Formation: MqsA Is Transcriptionally Uncoupled From mqsR, mBio, 10, e02678, 10.1128/mBio.02678-19 · DOI
  76. Rahman, 2023, An Isogenic
  77. Nazari, 2024, Investigating the Effectiveness of mqsR-Peptide Nucleic Acid as a Novel Solution for the Eradication of Persister Cells in Clinical Isolates of Escherichia Coli, Clin Lab, 70, 10.7754/Clin.Lab.2023.230406 · doi:10.7754/clin.lab.2023.230406
  78. Bustamante, 2024, Contribution of Toxin–Antitoxin Systems to Adherent-Invasive E. Coli Pathogenesis, Microorganisms, 12, 1158, 10.3390/microorganisms12061158 · DOI
  79. Edelmann, 2021, Elevated Expression of Toxin TisB Protects Persister Cells Against Ciprofloxacin But Enhances Susceptibility to Mitomycin C, Microorganisms, 9, 943, 10.3390/microorganisms9050943 · DOI
  80. Brown, 2019, Nitrogen Starvation Induces Persister Cell Formation in Escherichia Coli, J Bacteriol, 201, e00622, 10.1128/JB.00622-18 · doi:10.1128/jb.00622-18
  81. Liu, 2024, Gene Regulatory Mechanism of Mycobacterium Tuberculosis During Dormancy, Curr Issues Mol Biol, 46, 5825, 10.3390/cimb46060348 · DOI
  82. Zamakhaev, 2022, VapC Toxin Switches M. Smegmatis Cells Into Dormancy Through 23S rRNA Cleavage, Arch Microbiol, 205, 28, 10.1007/s00203-022-03363-1 · DOI
  83. Kundu, 2021, Applications of Transcriptomics and Proteomics for Understanding Dormancy and Resuscitation in Mycobacterium Tuberculosis, Front Microbiol, 12, 642487, 10.3389/fmicb.2021.642487 · DOI
  84. Ehrhardt, 2023, Determinants of Persistent Salmonella Infections, Curr Opin Immunol, 82, 102306, 10.1016/j.coi.2023.102306 · DOI
  85. Demidenok, 2014, Toxin-Antitoxin vapBC Locus Participates in Formation of the Dormant State in Mycobacterium Smegmatis, FEMS Microbiol Lett, 352, 69, 10.1111/1574-6968.12380 · doi:10.1111/1574-6968.12380
  86. Slattery, 2013, Isolation of Highly Persistent Mutants of Salmonella Enterica Serovar Typhimurium Reveals a New Toxin-Antitoxin Module, J Bacteriol, 195, 647, 10.1128/JB.01397-12 · DOI
  87. Irving, 2021, The Stringent Response and Physiological Roles of (Pp) pGpp in Bacteria, Nat Rev Microbiol, 19, 256, 10.1038/s41579-020-00470-y · DOI · Paper page
  88. Pacios, 2020, (p) ppGpp and Its Role in Bacterial Persistence: New Challenges, Antimicrob Agents Chemother, 64, e01283, 10.1128/AAC.01283-20 · DOI
  89. Kundra, 2020, Survival of the Fittest: The Relationship of (P) ppGpp With Bacterial Virulence, Front Microbiol, 11, 601417, 10.3389/fmicb.2020.601417 · DOI
  90. Das, 2020, (p) ppGpp Metabolism and Antimicrobial Resistance in Bacterial Pathogens, Front Microbiol, 11, 563944, 10.3389/fmicb.2020.563944 · DOI
  91. Kamruzzaman, 2021, Biological Functions of Type II Toxin-Antitoxin Systems in Bacteria, Microorganisms, 9, 1276, 10.3390/microorganisms9061276 · DOI
  92. Zhang, 2020, Type II Toxin–Antitoxin System in Bacteria: Activation, Function, and Mode of Action, Biophys Rep, 6, 68, 10.1007/s41048-020-00109-8 · DOI
  93. Ghazaei, 2022, Advances in the Study of Bacterial Toxins, Their Roles and Mechanisms in Pathogenesis, The Malaysian J Med Sci MJMS, 29, 4, 10.21315/mjms2022.29.1.2 · DOI
  94. Tu, 2020, Evaluating the Potential for Cross-Interactions of Antitoxins in Type II TA Systems, Toxins, 12, 422, 10.3390/toxins12060422 · doi:10.3390/toxins12060422
  95. Kaldalu, 2020, In Vitro Studies of Persister Cells, Microbiol Mol Biol Rev, 84, e00070, 10.1128/MMBR.00070-20 · DOI
  96. Gelens, 2013, A General Model for Toxin-Antitoxin Module Dynamics Can Explain Persister Cell Formation in E. Coli, PLoS Comput Biol, 9, e1003190, 10.1371/journal.pcbi.1003190 · DOI
  97. Fasani, 2013, Molecular Mechanisms of Multiple Toxin–Antitoxin Systems Are Coordinated to Govern the Persister Phenotype, Proc Natl Acad Sci USA, 110, E2528, 10.1073/pnas.1301023110 · DOI
  98. Windels, 2024, Antibiotic Dose and Nutrient Availability Differentially Drive the Evolution of Antibiotic Resistance and Persistence, ISME J, 18, wrae070, 10.1093/ismejo/wrae070 · DOI
  99. Boeck, 2023, Antibiotic Tolerance: Targeting Bacterial Survival, Curr Opin Microbiol, 74, 102328, 10.1016/j.mib.2023.102328 · DOI
  100. Amarh, 2019, DNA Double-Strand Break Formation and Repair as Targets for Novel Antibiotic Combination Chemotherapy, Future Sci OA, 5, FSO411, 10.2144/fsoa-2019-0034 · DOI
  101. Lebeaux, 2014, pH-Mediated Potentiation of Aminoglycosides Kills Bacterial Persisters and Eradicates In Vivo Biofilms, J Infect Dis, 210, 1357, 10.1093/infdis/jiu286 · DOI
  102. Yee, 2022, Eradication of Staphylococcus Aureus Biofilm Infection by Persister Drug Combination, Antibiotics (Basel), 11, 1278, 10.3390/antibiotics11101278 · DOI
  103. Mayorga-Ramos, 2023, CRISPR-Cas-Based Antimicrobials: Design, Challenges, and Bacterial Mechanisms of Resistance, ACS Infect Dis, 9, 1283, 10.1021/acsinfecdis.2c00649 · DOI · Paper page
  104. Casciaro, 2020, The Antimicrobial Peptide Temporin G: Anti-Biofilm, Anti-Persister Activities, and Potentiator Effect of Tobramycin Efficacy Against Staphylococcus Aureus, Int J Mol Sci, 21, 9410, 10.3390/ijms21249410 · DOI
  105. Cao, 2022, Gold Nanocluster Adjuvant Enables the Eradication of Persister Cells by Antibiotics and Abolishes the Emergence of Resistance, Nanoscale, 14, 10016, 10.1039/d2nr01003h · DOI
  106. Kim, 2011, Selective Killing of Bacterial Persisters by a Single Chemical Compound Without Affecting normal Antibiotic-Sensitive Cells, Antimicrob Agents Chemother, 55, 5380, 10.1128/AAC.00708-11 · DOI
  107. Queraltó C, 2023, Role and Regulation of Clp Proteases: A Target Against Gram-Positive Bacteria, Bacteria, 2, 21, 10.3390/bacteria2010002 · DOI
  108. Brötz-Oesterhelt, 2021, Reprogramming of the Caseinolytic Protease by ADEP Antibiotics: Molecular Mechanism, Cellular Consequences, Therapeutic Potential, Front Mol Biosci, 8, 690902, 10.3389/fmolb.2021.690902 · DOI
  109. Mroue, 2019, Pharmacodynamics of ClpP-Activating Antibiotic Combinations Against Gram-Positive Pathogens, Antimicrob Agents Chemother, 64, e01554, 10.1128/AAC.01554-19 · DOI
  110. Conlon, 2013, Activated ClpP Kills Persisters and Eradicates a Chronic Biofilm Infection, Nature, 503, 365, 10.1038/nature12790 · DOI · Paper page
  111. Wood, 2017, Strategies for Combating Persister Cell and Biofilm Infections, Microb Biotechnol, 10, 1054, 10.1111/1751-7915.12774 · DOI
  112. Alnahhas, 2023, Advances in Linking Single-Cell Bacterial Stress Response to Population-Level Survival, Curr Opin Biotechnol, 79, 102885, 10.1016/j.copbio.2022.102885 · DOI
  113. Sulaiman, 2021, Evolution of Bacterial Tolerance Under Antibiotic Treatment and Its Implications on the Development of Resistance, Front Microbiol, 12, 617412, 10.3389/fmicb.2021.617412 · DOI
  114. Martinecz, 2018, Estimating Treatment Prolongation for Persistent Infections, Pathog Dis, 76, fty065, 10.1093/femspd/fty065 · DOI
  115. Byndloss, 2016, Chronic Bacterial Pathogens: Mechanisms of Persistence, Microbiol Spectr, 4, 10, 10.1128/microbiolspec.VMBF-0020-2015 · DOI
  116. Joseph, 2024, Bacterial Persistence in Urinary Tract Infection Among Postmenopausal Population, Urogynecology, 30, 205, 10.1097/SPV.0000000000001452 · DOI
  117. Chebotar, 2021, The Classification of Bacterial Survival Strategies in the Presence of Antimicrobials, Microb Pathogenesis, 155, 104901, 10.1016/j.micpath.2021.104901 · DOI
  118. Windels, 2019, Antibiotics: Combatting Tolerance to Stop Resistance, mBio, 10, e02095, 10.1128/mBio.02095-19 · DOI · Paper page
  119. Ahmed, 2024, Antimicrobial Resistance: Impacts, Challenges, and Future Prospects, J Med Surg Public Health, 2, 100081, 10.1016/j.glmedi.2024.100081 · DOI · Paper page
  120. Brauner, 2016, Distinguishing Between Resistance, Tolerance and Persistence to Antibiotic Treatment, Nat Rev Microbiol, 14, 320, 10.1038/nrmicro.2016.34 · DOI · Paper page
  121. Trastoy, 2018, Mechanisms of Bacterial Tolerance and Persistence in the Gastrointestinal and Respiratory Environments, Clin Microbiol Rev, 31, e00023, 10.1128/CMR.00023-18 · DOI · Paper page
  122. Abbas, 2024, Antibiotic Resistance: A Key Microbial Survival Mechanism That Threatens Public Health, Cell Host & Microbe, 32, 837, 10.1016/j.chom.2024.05.015 · DOI · Paper page
  123. Dawan, 2022, Bacterial Stress Responses as Potential Targets in Overcoming Antibiotic Resistance, Microorganisms, 10, 1385, 10.3390/microorganisms10071385 · DOI · Paper page
  124. Kaushik, 2022, Antipersister Strategies Against Stress Induced Bacterial Persistence, Microb Pathogenesis, 164, 105423, 10.1016/j.micpath.2022.105423 · DOI
  125. Bi, 2018, Stimulus Sensing and Signal Processing in Bacterial Chemotaxis, Curr Opin Microbiol, 45, 22, 10.1016/j.mib.2018.02.002 · DOI · Paper page
  126. Amato, 2013, Metabolic Control of Persister Formation in Escherichia Coli, Mol Cell, 50, 475, 10.1016/j.molcel.2013.04.002 · DOI · Paper page
  127. Jiang, 2023, Ampicillin-Controlled Glucose Metabolism Manipulates the Transition From Tolerance to Resistance in Bacteria, Sci Adv, 9, eade8582, 10.1126/sciadv.ade8582 · DOI
  128. Li, 2019, The Resistance Mechanism of Escherichia Coli Induced by Ampicillin in Laboratory, Infect Drug Resist, 12, 2853, 10.2147/IDR.S221212 · DOI
  129. Huigens, 2021, Targeting Bacterial Biofilms With Persister-Killing Agents, Future Med Chem, 13, 225, 10.4155/fmc-2020-0314 · doi:10.4155/fmc-2020-0314
  130. Wexselblatt, 2012, Relacin, a Novel Antibacterial Agent Targeting the Stringent Response, PLoS Pathog, 8, e1002925, 10.1371/journal.ppat.1002925 · DOI · Paper page

Cited by

See all 108

Metadata

Authors
Kunnath, A. P., Suodha Suoodh, M., Chellappan, D. K., Chellian, J., & Palaniveloo, K.
Venue
British Journal of Biomedical Science
Published
2024-08-07
Volume
81
ISSN
2474-0896
Cited by
108
References
4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.